Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning...
In a report from November 2023, France’s Directorate General of Health (DGS) recommended the roll out of a temporary regulatory framework.
Approaching the sixth anniversary of the legalisation of medical cannabis in the UK, private prescriptions are on the rise, but broader awareness among professionals and the...
The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021.
Spanish regulators have taken another step towards introducing its long-delayed medical cannabis framework.
The study is thought to be among the first to examine long-term brain differences among patients using cannabis for medical symptoms.
The French ANSM assured at the beginning of the year that cannabis-based treatments would be available by 2025.
Releaf examines what to consider when exploring this treatment option for yourself or a loved one.
The proposed changes are set to have a major impact on the country’s already booming market.
The UK is the primary driver of new growth in Europe’s medical cannabis market, with sales of medical cannabis greater than expected due to ‘unusually high’...
